Panyakit ati lemak non-alkohol (NAFLD) mangrupikeun panyakit anu umum pisan. Pikeun langkung ngartos hubungan antara NAFLD sareng résiko karsinoma hépatoselular (HCC), peneliti di Baylor College of Medicine ngalaksanakeun kajian Retrospective anu ageung diterbitkeun dina "Gastroenterology".
Dina ulikan ieu, tim panalungtikan diulik grup ti Administrasi Kaséhatan Veterans sarta dituturkeun nepi pikeun ngeunaan 11 taun. Panaliti ieu kalebet 296,707 pasien anu dipikanyaho gaduh NAFLD sareng 296,707 pasien tanpa NAFLD. Diantara pasien NAFLD, 490 gaduh HCC, sareng résiko ngembangkeun HCC langkung luhur tibatan anu henteu NAFLD.
Dr Fasiha Kanwal, profesor jeung lulugu kadokteran, sareng kolega Anjeun manggihan yén penderita NAFLD kalawan Sirosis ati boga incidence pangluhurna HCC unggal taun. Résiko HCC naek kalawan umur, sarta manula Spanyol kalawan sirosis ati nyaéta HCC Grup-resiko tinggi.
“This study provides valuable and powerful information on which of the millions of NAFLD patients are at risk for HCC. This information is an important step forward in our understanding of the disease. For researchers, clinical Doctors and patients have important reference value, ” said Dr. Hashem EI-Serag, professor of gastroenterology at Baylor Medicine and senior author of the paper . Moreover, the results of this study also provide guidance for monitoring and risk adjustment for people at increased risk of kanker haté, such as patients with cirrhosis or diabetes.
